Sho Nakakubo

Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study

Sho Nakakubo, Naoki Kishida, Kenichi Okuda et al. · The Lancet Infectious Diseases · 2023 · 50 citations · Full text

Virus Epidemiology, Covid-19 Pandemic, Clinical Epidemiology +9

Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification

Tatsuya Fukumoto, Sumio Iwasaki, Shinichi Fujisawa et al. · International Journal of Infectious Diseases · 2020 · 45 citations · Full text

Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia

Akiko Yuno, Yoshiyuki Kenmotsu, Yuka Takahashi et al. · Endocrine Journal · 2020 · 19 citations · Full text

Coronavirus Disease 2019, Pituitary Surgery, Covid-19 Pandemic +9

Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study

Yuichi Kojima, Sho Nakakubo, Nozomu Takei et al. · Medicina · 2022 · 18 citations · Full text

Rapidly progressive organizing pneumonia associated with COVID-19

Hiroshi Horii, Keisuke Kamada, Sho Nakakubo et al. · Respiratory Medicine Case Reports · 2020 · 15 citations · Full text

Bilateral Lung Consolidation, Hokkaido University Hospital, Inflammatory Lung Disease +13